Patient Demography and Baseline Characteristics Were Similar Across Treatment Groups
Placebo SAL50 FP250 FP500 50 50
Variable n=572 n=337 n=399 n=386 n=178 n=165
Age (yrs) 65 64 65 64 63 62
Gender (% male) 70% 61% 69% 64% 61% 62%
Race (% white) 94% 94% 93% 94% 96% 95%
Curr Smoker % 48% 49% 46% 47% 43% 46%
Pack years 63 63 61 60 60 62
Prev ICS 27% 25% 29% 28% 23% 28%
FEV1 % pred 42% 41% 41% 41% 41% 41%
BD resp. (% pts rev) 57% 53% 57% 55% 56% 53%
Emphysema % 75% 72% 73% 74% 71% 75%